A ‘Human’ Touch vs. COVID-19

Should clinical trials prove positive, Humanigen envisions applying for a BLA, and based on the strength of its data obtaining emergency use authorization (EUA) for lenzilumab, followed by a launch of initial commercial activities as soon as the fourth quarter.

Janssen Launches Clinical Trials Database

Merck, Lilly join effort to house data on investigators and trial sites.

Mind-Altering Drug Stymies Asthma Development

Psychedelic drug prevents the development of allergic asthma in a mouse model.

Heptares Chooses Sygnature Chemical Services for Drug Discovery Contract

Sygnature Chemical Services will help Heptares Therapeutics progress one of its internal GPCR programs. Sygnature will use its synthetic chemistry expertise to produce a...

Viral Safety Testing: Keeping the Fly Out of the Ointment

Industry experts describe how viral safety testing is evolving to ensure that gene therapies and viral-mediated therapies move more quickly to clinic.

Seattle Genetics to Acquire Cascadian Therapeutics for $614M

Deal would expand buyer’s oncology pipeline with tucatinib, a breast cancer candidate now under study in a pivotal Phase II trial in patients with HER2+ metastatic breast cancer

Permira to Acquire Cambrex for $2.4B, Planning Growth in Consolidating CDMO...

Cambrex has agreed to be acquired by an affiliate of the global investment firm Permira for approximately $2.4 billion, in a deal the company said will position it for further growth in the consolidating contract development and manufacturing organization (CDMO) sector.

Parexel to Aid Lilly with Clinical Development in Asia-Pacific

Firm will take on study start-up and site monitoring.

Gates Foundation, EC Agree to Fight Poverty-Related Diseases

Partners pledge to support clinical trials, create collaborations between European and African countries.

COVID-19 Research: Women Are Changing the Face of the Pandemic

On the centenary of Rosalind Franklin’s birth, GEN declares that her example tells us that all women scientists deserve recognition. GEN sought to highlight scientists at the forefront of COVID-19 research—some of the most influential research currently being conducted—who are women. These researchers are leading efforts to track SARS-CoV-2 genomes, to uncover host factors influencing COVID-19 progression, to develop saliva-based COVID-19 tests, and more.